Tempest Therapeutics Inc.(TPST)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TPST Tempest Therapeutics Inc.

交易中 11-22 11:07:32 EST

0.8988

+0.0052

+0.58%

最高0.9088	最低0.8660	成交量23.37万
今开0.8913	昨收0.8936	日振幅4.79%
总市值3,923万	流通市值1,932万	总股本4,364万
成交额20.72万	换手率1.09%	流通股本2,150万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TPST","market":"US","secType":"STK","nameCN":"Tempest Therapeutics Inc.","latestPrice":0.8988,"timestamp":1732291649574,"preClose":0.8936,"halted":0,"volume":233734,"delay":0,"floatShares":21500600,"shares":43642072,"eps":-1.576823,"marketStatus":"交易中","marketStatusCode":2,"change":0.0052,"latestTime":"11-22 11:07:32 EST","open":0.8913,"high":0.9088,"low":0.866,"amount":207225.6894718,"amplitude":0.047896,"askPrice":0.9025,"askSize":100,"bidPrice":0.8951,"bidSize":105,"shortable":3,"etf":0,"ttmEps":-1.576823,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732309200000},"adr":0,"adjPreClose":0.8936,"preHourTrading":{"tag":"盘前","latestPrice":0.89,"preClose":0.8936,"latestTime":"09:27 EST","volume":18856,"amount":16793.851272,"timestamp":1732285651812},"postHourTrading":{"tag":"盘后","latestPrice":0.8998,"preClose":0.8936,"latestTime":"19:59 EST","volume":17433,"amount":15477.9602,"timestamp":1732237172102},"volumeRatio":0.44488,"impliedVol":0.597,"impliedVolPercentile":0.0754},"requestUrl":"/m/hq/s/TPST","defaultTab":"news","newsList":[{"id":"2484679806","title":"Tempest Therapeutics, Inc.盘中异动 急速跳水5.05%报0.845美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484679806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484679806?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:38","pubTimestamp":1731940737,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时38分，Tempest Therapeutics, Inc.股票出现异动，股价急速跳水5.05%。截至发稿，该股报0.845美元/股，成交量15.7584万股，换手率0.36%，振幅2.25%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。其处于临床阶段的候选治疗产品是 TPST-1120 和 TPST-1495，这两个临床阶段的分子被设计于抑制各自的靶点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822385798e4340c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822385798e4340c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TPST","LENZ"],"gpt_icon":0},{"id":"2483385648","title":"Tempest Therapeutics, Inc.2024财年第三财季实现净利润-10.56百万美元，同比减少55.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483385648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483385648?lang=zh_cn&edition=full","pubTime":"2024-11-15 00:00","pubTimestamp":1731600023,"startTime":"0","endTime":"0","summary":"11月15日，Tempest Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-10.56百万美元，同比减少55.52%；其中营业收入为0.00美元，每股基本收益为-0.41美元。机构评级：截至2024年11月15日，当前有4家机构对Tempest Therapeutics, Inc.目标价做出预测，其中目标均价为18.75美元，其中最低目标价为5.00美元，最高目标价为47.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115000026a237ff54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115000026a237ff54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TPST"],"gpt_icon":0},{"id":"2483804274","title":"Tempest Therapeutics, Inc.盘中异动 早盘大幅拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483804274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483804274?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:52","pubTimestamp":1731595926,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时52分，Tempest Therapeutics, Inc.股票出现异动，股价快速拉升5.01%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422520698e42a92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422520698e42a92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TPST","BK4139","LENZ"],"gpt_icon":0},{"id":"2483884534","title":"Tempest Therapeutics, Inc.股价重挫12.04% 市值跌288.32万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483884534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483884534?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:31","pubTimestamp":1731508268,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时31分，Tempest Therapeutics, Inc.股票出现波动，股价急速下跌12.04%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322310895be2306&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322310895be2306&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","TPST"],"gpt_icon":0},{"id":"2481821132","title":"Tempest Therapeutics, Inc.盘中异动 下午盘快速拉升5.77%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481821132","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481821132?lang=zh_cn&edition=full","pubTime":"2024-11-08 02:22","pubTimestamp":1731003749,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日02时22分，Tempest Therapeutics, Inc.股票出现波动，股价大幅上涨5.77%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.03%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110802223098e41441&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110802223098e41441&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TPST","LENZ"],"gpt_icon":0},{"id":"2481307535","title":"Tempest Therapeutics, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481307535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481307535?lang=zh_cn&edition=full","pubTime":"2024-11-05 02:42","pubTimestamp":1730745726,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日02时42分，Tempest Therapeutics, Inc.股票出现异动，股价急速拉升5.01%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105024206971a43b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105024206971a43b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TPST","BK4139","LENZ"],"gpt_icon":0},{"id":"2480558009","title":"Tempest Therapeutics Inc   预计每股亏损36美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480558009","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480558009?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:48","pubTimestamp":1730735305,"startTime":"0","endTime":"0","summary":"   * Tempest Therapeutics Inc    将于11月6日公布截至2024年9月30日的财报() 预计季度营收将保持不变。*    * LSEG分析师对Tempest Therapeutics Inc的平均预期是每股亏损36美分。* 华尔街对 Tempest Therapeutics Inc 的 12 个月目标价中位数为 13.00 美元，高于上一交易日 0.91 美元的收盘价。11月4日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","LENZ"],"gpt_icon":0},{"id":"2480288279","title":"Tempest Therapeutics, Inc.盘中异动 股价大涨5.23%报0.963美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480288279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480288279?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:24","pubTimestamp":1730471065,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日22时24分，Tempest Therapeutics, Inc.股票出现波动，股价急速拉升5.23%。截至发稿，该股报0.963美元/股，成交量90.9101万股，换手率3.61%，振幅7.65%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110122242598e40070&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110122242598e40070&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TPST","LENZ"],"gpt_icon":0},{"id":"2479788931","title":"Tempest Therapeutics, Inc.盘中异动 股价大跌14.55%报0.940美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479788931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479788931?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:30","pubTimestamp":1730295003,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时30分，Tempest Therapeutics, Inc.股票出现异动，股价急速下跌14.55%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Renovorx, Inc.、Newamsterdam Pharma Company N.V.、Zymeworks Inc.涨幅较大，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.较为活跃，换手率分别为1587.33%、91.57%、13.62%，振幅较大的相关个股有Tempest Therapeutics, Inc.、Zymeworks Inc.、Zyversa Therapeutics, Inc.，振幅分别为0.70%、0.00%、0.00%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030213003971a3397&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030213003971a3397&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TPST","LENZ"],"gpt_icon":0},{"id":"2477154638","title":"Tempest Therapeutics, Inc.盘中异动 大幅下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477154638","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477154638?lang=zh_cn&edition=full","pubTime":"2024-10-22 03:57","pubTimestamp":1729540650,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日03时57分，Tempest Therapeutics, Inc.股票出现异动，股价快速下挫5.00%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.04%。其相关个股中，Genprex, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Gri Bio, Inc.涨幅较大，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃，换手率分别为10609.02%、3938.19%、1814.16%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为369.73%、216.60%、151.00%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102203573098e3d9af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102203573098e3d9af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TPST","BK4139"],"gpt_icon":0},{"id":"2476178845","title":"Tempest Therapeutics, Inc.盘中异动 早盘股价大涨5.40%报1.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476178845","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476178845?lang=zh_cn&edition=full","pubTime":"2024-10-17 21:33","pubTimestamp":1729172012,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日21时33分，Tempest Therapeutics, Inc.股票出现波动，股价快速拉升5.40%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101721333298e3cff1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101721333298e3cff1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","TPST"],"gpt_icon":0},{"id":"2474092651","title":"Tempest Therapeutics, Inc.盘中异动 股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474092651","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474092651?lang=zh_cn&edition=full","pubTime":"2024-10-11 21:34","pubTimestamp":1728653655,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日21时34分，Tempest Therapeutics, Inc.股票出现异动，股价大幅跳水5.35%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101121341598e3bdf8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101121341598e3bdf8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TPST","BK4139"],"gpt_icon":0},{"id":"2474725558","title":"Tempest Therapeutics(TPST)与罗氏(RHHBY)达成协议推进肝癌药物研究 惟股价跌超22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474725558","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474725558?lang=zh_cn&edition=full","pubTime":"2024-10-10 23:39","pubTimestamp":1728574757,"startTime":"0","endTime":"0","summary":"金吾财讯 | Tempest Therapeutics(TPST)盘初一度大涨约18%，截至发稿，跌超24%，报1.025美元。消息面上，Tempest Therapeutics将对其实验药物amezalpat与瑞士制药商罗氏(RHHBY)的Tecentriq和贝伐珠单抗联合使用进行后期研究，以治疗转移性肝细胞癌。根据协议，罗氏将在全球范围内供应Tecentriq，Tempest将赞助并领导这项研究。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/NGU1YzNhMmY0MDcxNDc2NDI4MDI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NGU1YzNhMmY0MDcxNDc2NDI4MDI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"280795","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","03165","LENZ","TPST","RHHBY","BK4007"],"gpt_icon":0},{"id":"2474740875","title":"BUZZ--美国股票走势-空气产品公司、辉瑞公司、贝宝公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2474740875","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474740875?lang=zh_cn&edition=full","pubTime":"2024-10-10 23:02","pubTimestamp":1728572562,"startTime":"0","endTime":"0","summary":"标普500指数  下跌0.24%，报 5778 .03点；纳斯达克综合指数  下跌0.18%，报18258.921点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c21f7907349b7846aede8ba1803fd0ec","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACIC","DAL","LU1917777945.USD","PYPL","QID","AIG","LU1066053197.SGD","LU0170899867.USD","UVE",".DJI","LU2326559502.SGD","SDOW","GXO","SG9999002232.USD","TD","HRTG","LU2065170008.USD","APD","LU1712237335.SGD",".IXIC","TQQQ","SWKS","LU0320765489.SGD","MNQmain","QLD","IE00BKVL7J92.USD","TPST","HII","DXD","NOVA","SQQQ","PSQ","NQmain","DDM","EBAY","LU1623119135.USD","LU2506951792.HKD","VRSK","FSLR","GRTS","PFE","DJX","DOG",".SPX","UDOW","BK4500","LU0957808578.USD","CVS"],"gpt_icon":1},{"id":"2474745800","title":"BUZZ-Tempest Therapeutics与罗氏达成协议，推进肝癌药物研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2474745800","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474745800?lang=zh_cn&edition=full","pubTime":"2024-10-10 21:17","pubTimestamp":1728566227,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    10月10日 - ** 药物开发商Tempest Therapeutics   股价盘前上涨19.21%，报1.60美元** TPST将对其实验药物amezalpat与瑞士制药商罗氏公司  的Tecentriq和贝伐珠单抗联合使用进行后期研究，以治疗转移性肝细胞癌（一种肝癌）。 ** 根据协议，罗氏将在全球范围内供应Tecentriq，Tempest将赞助并领导这项研究** 公司准备在 2025 年第一季度开始晚期研究** TPST保留amezalpat的所有开发和商业权利** 截至上一交易日收盘，Tempest股价年累计下跌69.32%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","LENZ","BK4139"],"gpt_icon":0},{"id":"2474127555","title":"Tempest Therapeutics, Inc.盘中异动 股价大跌5.04%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474127555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474127555?lang=zh_cn&edition=full","pubTime":"2024-10-10 00:09","pubTimestamp":1728490151,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日00时09分，Tempest Therapeutics, Inc.股票出现异动，股价大幅下跌5.04%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410100009129719f4d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410100009129719f4d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TPST","BK4139","LENZ"],"gpt_icon":0},{"id":"2471385556","title":"Tempest Therapeutics, Inc.盘中异动 早盘急速上涨5.84%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471385556","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471385556?lang=zh_cn&edition=full","pubTime":"2024-09-30 21:48","pubTimestamp":1727704110,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日21时48分，Tempest Therapeutics, Inc.股票出现波动，股价快速上涨5.84%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930214830ab672838&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930214830ab672838&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TPST","LENZ"],"gpt_icon":0},{"id":"2468570893","title":"Tempest Therapeutics, Inc.盘中异动 早盘股价大涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468570893","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468570893?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:35","pubTimestamp":1726752903,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时35分，Tempest Therapeutics, Inc.股票出现波动，股价快速拉升5.39%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。其相关个股中，Exicure, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为1073.39%、383.29%、73.77%，振幅较大的相关个股有Exicure, Inc.、Portage Biotech Inc.、Transcode Therapeutics, Inc.，振幅分别为54.59%、18.97%、16.57%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213503a1db316b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213503a1db316b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TPST","BK4139","LENZ"],"gpt_icon":0},{"id":"2460717466","title":"Tempest Therapeutics, Inc.2024财年第二财季实现净利润-9.57百万美元，同比减少26.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460717466","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460717466?lang=zh_cn&edition=full","pubTime":"2024-08-19 00:00","pubTimestamp":1723996855,"startTime":"0","endTime":"0","summary":"8月19日，Tempest Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-9.57百万美元，同比减少26.25%；其中营业收入为0.00美元，每股基本收益为-0.42美元。机构评级：截至2024年8月19日，当前有4家机构对Tempest Therapeutics, Inc.目标价做出预测，其中目标均价为19.50美元，其中最低目标价为8.00美元，最高目标价为47.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081900010895a38414&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081900010895a38414&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TPST","LENZ"],"gpt_icon":1},{"id":"2459640629","title":"BUZZ--美国股票走势-波音、AST SpaceMobile、Syndax","url":"https://stock-news.laohu8.com/highlight/detail?id=2459640629","media":"Reuters","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459640629?lang=zh_cn&edition=full","pubTime":"2024-08-16 02:24","pubTimestamp":1723746298,"startTime":"0","endTime":"0","summary":"美东时间13:48，标普500指数  上涨1.51%，报5537.6点；纳斯达克综合指数  上涨2.17%，报17565.784点。** Peloton Interactive Inc   ：上涨 10.8 BUZZ - 在报导了艾因霍恩的新持股后上涨   ** Spire Global Inc   ：下跌 32.5% BUZZ - 因会计问题导致业绩延迟而下滑   ** 维多利亚的秘密   ：上涨 7.8 BUZZ - 因摩根士丹利将其评级上调至 \"等权重 \"而上涨   ** Nvidia Corp   ：上涨 3.9** 英特尔公司  ：上涨 4.3** Wolfspeed Inc","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2463526074.USD","ASTS","MGM","LU0354030511.USD","BK4547","LU0251142724.SGD","NEM","SIRI","TJX","DLTR","DVN","SCPH","MNQmain","LLAP","FCX","RILY","CVX","BA","BK4200","ROST","ARAY","PSQ","UNP","PSX","NQmain","TQQQ","TPST","CARR","TGT","PTON","QLD","SCCO","XOM","SIGA",".SPX","BK4525","SQQQ","LU0354030438.USD",".IXIC","LU0795875086.SGD","QID","LU0098860793.USD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.tempesttx.com","stockEarnings":[{"period":"1week","weight":-0.0789},{"period":"1month","weight":-0.149},{"period":"3month","weight":-0.3707},{"period":"6month","weight":-0.7246},{"period":"1year","weight":-0.7867},{"period":"ytd","weight":-0.7969}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tempest Therapeutics Inc成立于2011年4月5日。该公司是一家临床阶段的肿瘤学公司，专注于利用对癌症生物学和药物化学的深刻科学理解，开发和推进用于治疗实体瘤的新型口服疗法。该公司正在推进两个候选产品TPST-1120和TPST-1495的临床试验，它们被认为是第一个被设计用于抑制各自靶点的临床阶段分子；以及两个临床前项目，其中一个可能是第一个靶向TREX-1的项目，TREX-1是一种调节肿瘤先天免疫反应的关键细胞酶。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.011023},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.013716},{"month":3,"riseRate":0.545455,"avgChangeRate":0.034268},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.129414},{"month":5,"riseRate":0.5,"avgChangeRate":0.018957},{"month":6,"riseRate":0.25,"avgChangeRate":-0.112553},{"month":7,"riseRate":0.083333,"avgChangeRate":-0.065856},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.089732},{"month":9,"riseRate":0.5,"avgChangeRate":-0.067189},{"month":10,"riseRate":0.5,"avgChangeRate":1.025612},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.036207},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.053509}],"exchange":"NASDAQ","name":"Tempest Therapeutics Inc.","nameEN":"Tempest Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tempest Therapeutics Inc.(TPST)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tempest Therapeutics Inc.(TPST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tempest Therapeutics Inc.,TPST,Tempest Therapeutics Inc.股票,Tempest Therapeutics Inc.股票老虎,Tempest Therapeutics Inc.股票老虎国际,Tempest Therapeutics Inc.行情,Tempest Therapeutics Inc.股票行情,Tempest Therapeutics Inc.股价,Tempest Therapeutics Inc.股市,Tempest Therapeutics Inc.股票价格,Tempest Therapeutics Inc.股票交易,Tempest Therapeutics Inc.股票购买,Tempest Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tempest Therapeutics Inc.(TPST)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tempest Therapeutics Inc.(TPST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}